n | Consultations before referral n (%) | ||||
---|---|---|---|---|---|
1 | 2 | 3–4 | ≥5 | ||
Small intestine | 218 | 50 (22.9) | 37 (17.0) | 60 (27.5) | 71 (32.6) |
Multiple myeloma | 2052 | 632 (30.8) | 451 (22.0) | 584 (28.5) | 385 (18.8) |
Pancreatic | 1137 | 374 (32.9) | 278 (24.5) | 277 (24.4) | 208 (18.3) |
Liver | 451 | 177 (39.2) | 107 (23.7) | 105 (23.3) | 62 (13.7) |
Bone sarcoma | 196 | 75 (38.3) | 40 (20.4) | 52 (26.5) | 29 (14.8) |
Brain | 474 | 193 (40.7) | 95 (20.0) | 107 (22.6) | 79 (16.7) |
Stomach | 1828 | 746 (40.8) | 459 (25.1) | 394 (21.6) | 229 (12.5) |
Hodgkin lymphoma | 969 | 314 (32.4) | 238 (24.6) | 239 (24.7) | 178 (18.4) |
Colon | 8053 | 3424 (42.5) | 1989 (24.7) | 1713 (21.3) | 927 (11.5) |
Gallbladder | 66 | 27 (40.9) | 16 (24.2) | 15 (22.7) | 8 (12.1) |
Non-Hodgkin lymphoma | 5523 | 2372 (42.9) | 1307 (23.7) | 1187 (21.5) | 657 (11.9) |
Cancer of unknown primary | 3537 | 1585 (44.8) | 763 (21.6) | 733 (20.7) | 456 (12.9) |
Ureteric | 331 | 151 (45.6) | 80 (24.2) | 69 (20.8) | 31 (9.4) |
Lung | 6405 | 2628 (41.0) | 1709 (26.7) | 1301 (20.3) | 767 (12.0) |
All other | 2281 | 979 (42.9) | 549 (24.1) | 465 (20.4) | 288 (12.6) |
Mesothelioma | 641 | 268 (41.8) | 193 (30.1) | 130 (20.3) | 50 (7.8) |
Laryngeal | 667 | 303 (45.4) | 166 (24.9) | 133 (19.9) | 65 (9.7) |
Soft-tissue sarcoma | 508 | 218 (42.9) | 128 (25.2) | 109 (21.5) | 53 (10.4) |
Ovarian | 2717 | 1157 (42.6) | 647 (23.8) | 588 (21.6) | 325 (12.0) |
Renal | 1436 | 673 (46.9) | 332 (23.1) | 273 (19.0) | 158 (11.0) |
Oropharyngeal | 1155 | 517 (44.8) | 300 (26.0) | 250 (21.6) | 88 (7.6) |
Leukaemia | 2043 | 1016 (49.7) | 445 (21.8) | 373 (18.3) | 209 (10.2) |
Oesophageal | 2887 | 1437 (49.8) | 713 (24.7) | 539 (18.7) | 198 (6.9) |
Anal | 495 | 252 (50.9) | 110 (22.2) | 85 (17.2) | 48 (9.7) |
Penile | 174 | 94 (54.0) | 42 (24.1) | 29 (16.7) | 9 (5.2) |
Prostate | 8538 | 4045 (47.4) | 2630 (30.8) | 1329 (15.6) | 534 (6.3) |
Rectum | 5616 | 3094 (55.1) | 1257 (22.4) | 888 (15.8) | 377 (6.7) |
Bladder | 6837 | 3961 (57.9) | 1479 (21.6) | 974 (14.2) | 423 (6.2) |
Cervical | 706 | 372 (52.7) | 131 (18.6) | 115 (16.3) | 88 (12.5) |
Vulval/vaginal | 405 | 235 (58.0) | 75 (18.5) | 59 (14.6) | 36 (8.9) |
Parotid | 140 | 71 (50.7) | 37 (26.4) | 22 (15.7) | 10 (7.1) |
Thyroid | 940 | 532 (56.6) | 211 (22.4) | 133 (14.1) | 64 (6.8) |
Oral | 567 | 330 (58.2) | 143 (25.2) | 71 (12.5) | 23 (4.1) |
Endometrial | 3255 | 2145 (65.9) | 561 (17.2) | 365 (11.2) | 184 (5.7) |
Testicular | 665 | 437 (65.7) | 132 (19.8) | 77 (11.6) | 19 (2.9) |
Melanoma | 3470 | 2576 (74.2) | 605 (17.4) | 233 (6.7) | 56 (1.6) |
Ductal carcinoma in situ | 650 | 535 (82.3) | 79 (12.2) | 32 (4.9) | 4 (0.6) |
Breast | 17 549 | 14 988 (85.4) | 1678 (9.6) | 639 (3.6) | 244 (1.4) |
↵a Cancer diagnoses are ordered as they appear in Table 2; rarer cancers without prior published evidence are denoted in bold italics.